OncLive SOSS
  • MJHLS Brand Logo

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2021 MJH Life Sciences™ and OncLive. All rights reserved.

Treatment Approach in Advanced Melanoma

January 8, 2021
Axel Hauschild, MD, PhD, University Hospital Schleswig-Holstein

,
Dirk Schadendorf, MD, University Hospital Essen

Deciding Between Adjuvant Targeted Therapy and Immunotherapy in BRAF+ Melanoma
PFS Deserves More Than Surrogate Status as a Clinical Trial End Point
Dr. Sullivan on Sequencing Targeted Therapy and Immunotherapy in Melanoma
x